New York State Common Retirement Fund’s Kyverna Therapeutics KYTX Stock Holding History

New York State Common Retirement Fund’s Portfolio KYTX Stock Details KYTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.2K	Buy	+9,000	New	+$79.9K	﹤0.01%	2800
2025 Q2	–	Sell	-4,500	Closed	-$8.69K	–	3364
2025 Q1	$8.69K	Hold	4,500	–	–	﹤0.01%	3092
2024 Q4	$16.8K	Hold	4,500	–	–	﹤0.01%	3070
2024 Q3	$22K	Sell	4,500 -9,100	-67%	-$70.2K	﹤0.01%	3030
2024 Q2	$102K	Buy	13,600 +13,417	+7,332%	+$205K	﹤0.01%	2801
2024 Q1	$4.55K	Buy	+183	New	+$5.11K	﹤0.01%	3217

Other funds holding KYTX

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

SIC

Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

New York State Common Retirement Fund's KYTX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 9,000 shares worth $80.2K. The stake represents ﹤0.01% of the portfolio and ranks #2800 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in KYTX as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in KYTX in Q1 2024 and has held it in 6 quarters since. The position peaked at $102K in Q2 2024. 21 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

New York State Common Retirement Fund held 9,000 shares of Kyverna Therapeutics worth $80.2K as of Q2 2026.
Kyverna Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
Kyverna Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2800 holding.
New York State Common Retirement Fund first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 6 quarters since.
New York State Common Retirement Fund's Kyverna Therapeutics position peaked at $102K in Q2 2024.
21 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.